Chemokine behavior of urotensin II through activation of pleiotropic receptor signaling pathways in glioblastoma: key mechanisms and potential targeting with nanoparticles

Pierre-Olivier Guichet (1, 2) , Céline Lecointre (3, 2) , Vadim Le Joncour (2) , M Freddy , Nicolas Perzo (4, 2) , Jane Eilen Joubert (2) , Pierre-Michaël Coly (2) , Fabrice Morin (2) , Annie Laquerriere (5) , François Proust (6, 2) , Pierrick Gandolfo (2) , Aa Edwards , V Gubala , Hélène Castel (2)

1 INM - Institut des Neurosciences de Montpellier
2 DC2N - Différenciation et communication neuronale et neuroendocrine
3 CRBM - Centre de recherche en Biologie Cellulaire
4 UdeS - Université de Sherbrooke
5 Service d'Anatomie et Cytologie Pathologique [CHU Rouen]
6 Hôpital de Hautepierre [Strasbourg]

Domaines: Sciences du Vivant [q-bio]; Cancer

Pierre-Olivier Guichet, Céline Lecointre, Vadim Le Joncour, M Freddy, Nicolas Perzo, et al.. Chemokine behavior of urotensin II through activation of pleiotropic receptor signaling pathways in glioblastoma: key mechanisms and potential targeting with nanoparticles. IUPAC, Nanomaterials and Human Health: Trends and Future, Sep 2014, Canterbury, United Kingdom. ⟨hal-02295896⟩